Organism | Number | Proportion Resistant | Resistance Phenotype |
---|---|---|---|
Gram-positives | |||
Staphylococcus aureus | 2 | 0 (0%) | – |
Methicillin-sensitive Staphylococcus aureus (MSSA) | 104 | 0 (0%) | – |
Methicillin-resistant Staphylococcus aureus (MRSA) | 132 | 132 (100%) | Methicillin resistance |
Coagulase-negative staphylococci (CNS) | 99 | 30 | Unknown resistance (24) |
Vancomycin-resistant enterococci (VRE), unspecified | 4 | 4 (100%) | Vancomycin resistance |
Enterococcus faecalis | 29 | 1 (3%) | High-level aminoglycoside resistance |
Enterococcus faecium | 33 | 6 (18%) | Vancomycin resistance (3); high-level aminoglycoside resistance (3), ampicillin resistance (1) |
Enterococcus casseliflavus/Enterococcus gallinarum | 2 | 1 (50%)* | Vancomycin resistance (1 – E. gallinarum)* |
Enterococcus spp. | 12 | 0 (0%) | – |
Streptococcus pneumoniae | 15 | 3 (20%) | Amoxicillin, amoxicillin/clavulanic acid, cefoxitin, gentamicin, erythromycin, clindamycin, piperacillin/tazobactam, trimethoprim/sulfamethoxazole (2); amikacin, ciprofloxacin, levofloxacin, cefotaxime, ceftriaxone, ceftazidime, cefepime (1), unknown resistance (1) |
Streptococcus spp. | 4 | 0 (0%) | – |
Clostridium difficile | 7 | 0 (0%) | – |
Gram-negatives | |||
Acinetobacter baumannii | 218 | 148 (68%) | Wide-spread resistance except to colistin (98); 26 isolates harbored OXA-23, 2 harbored NDM; Carbapenem resistance (4); extensively resistant (5), pan-drug resistant (3), unknown resistance (19) |
Klebsiella pneumoniae | 274 | 169 (62%) | 26 (carbapenem-producing KPC), OXA-48 (7), ESBL (13), NDM (1), multi-drug resistant (23), Carbapenem resistance (13), KPC-2 (1), KPC-3 (1), unknown resistance (25), VIM (1) |
Klebsiella oxytoca | 5 | 2 (40%) | ESBL (2) |
Klebsiella aerogenes | 4 | 0 (0%) | – |
Klebsiella spp. | 9 | 0 (0%) | – |
Pseudomonas spp. | 4 | 0 (0%) | – |
Pseudomonas aeruginosa | 203 | 65 (25%) | Unknown resistance (34), piperacillin/tazobactam (4), carbapenems (18), MDR (6), cephalosporin resistance (1), XDR (1) |
Serratia marcescens | 18 | 17 (94%) | Resistance to amoxicillin, amoxicillin/-clavulanic acid, 1st and 2nd generation cephalosporins (including AmpC B-lactamase) with low level of resistance to amikacin, multi-drug resistant (7) |
Escherichia coli | 118 | 43 (36%) | ESBL (2), AmpC resistance (1), multi-drug resistant (12), unknown resistance (18) |
Stenotrophomonas maltophilia | 60 | 24 (40%) | Multidrug resistant (24) |
Proteus mirabilis | 5 | 0 (0%) | – |
Proteus putida | 1 | 0 (0%) | – |
Haemophilus influenzae | 7 | 0 (0%) | – |
Moraxella catarrhalis | 1 | 0 (0%) | – |
Enterobacteriaceae, unspecified | 5 | 0 (0%) | – |
Yersinia enterocolitica | 1 | 1 (100%) | Amoxicillin and amoxicillin/-clavulanic acid resistance |
Enterobacter spp. | 8 | 5 (63%) | Imipenem resistance |
Enterobacter aerogenes | 8 | 8 (100%) | Carbapenem-resistant Enterobacteriaceae (1), ESBL (1), AmpC B lactamase (6), unknown resistance (1) |
Enterobacter cloacae | 68 | 29 (43%) | AmpC B lactamase (7), multi-drug resistant (18), NDM-1 (2) |
Elizabethkingia meningoseptica | 1 | 1 (100%) | Multi-drug resistant (1) |
Chryseobacterium gleum | 1 | 1 (100%) | Multi-drug resistant (1) |
Citrobacter koseri | 1 | 0 (0%) | – |
Mycoplasma pneumoniae | 2 | 0 (0%) | – |
Enterobacterales | 113 | 34 (30%) | Cephalosporin resistance (2); Carbapenem resistance (3), unknown resistance (29) |
Bacteroides fragilis | 2 | 0 (0%) | – |
Viral organisms | |||
Metapneumovirus | 1 | 0 (0%) | – |
Fungal organisms | |||
Candida auris | 11 | 10 (91%) | Fluconazole resistance (10), Voriconazole non-susceptible (3); overall 3 multi-azole resistant (fluconazole + voriconazole), 7 multi-drug resistant including 3 to 3 classes of drugs (azoles, amphotericin B and 5-flucytosine) and 4 resistant to 2 classes of drugs (azoles + 5-flucytosine and azoles + amphotericin B) |
Candida albicans | 88 | 3 (3%) | Fluconazole and voriconazole resistance (3); caspofungin intermediate (2) |
Candida dubliniensis | 6 | 2 (33%) | Fluconazole resistance (1), caspofungin resistance (1) |
Candida parapsilosis | 25 | 1 (4%) | Fluconazole resistance |
Candida glabrata | 15 | 1 (7%) | Pan-echinocandin resistance (1), caspofungin intermediate (7) |
Candida spp. | 22 | 5 (23%) | Azole resistance (5); Echinocandin resistance (1) |
Pichia kudriavzevii | 1 | 1 (100%) | Caspofungin and fluconazole resistance |
Aspergillus fumigatus | 3 | 0 (0%) | – |
Aspergillus flavus | 7 | 0 (0%) | – |
Aspergillus niger | 2 | 0 (0%) | – |
Other | 73 | 20 (27%) | Unknown resistance (9), ESBL (11) |